SCHEMBL23979799

SCHEMBL23979799

Cc1cccc2ccnc(C(C)N)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN4A P35499 5/20 0.36
▸ LMNA P02545 4/20 0.36
▸ MAOA P21397 3/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ SCN1A P35498 2/20 0.36
▸ SCN5A Q14524 2/20 0.36
▸ SCN9A Q15858 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ NFKB1 P19838 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KCNK3 O14649 1/20 0.36
▸ CACNA1F O60840 1/20 0.36
▸ KCNK2 O95069 1/20 0.36
▸ GBA1 P04062 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ SCN7A Q01118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23979528 0.86 MAOA (0.38) LMNAMAOACYP3A4CYP1A2CYP2D6
SCHEMBL23979549 0.81 PNMT (0.41) LMNAMAOACYP3A4CYP1A2CYP2D6
SCHEMBL24579781 0.79 MAOA (0.33) LMNAMAOACYP3A4TSHRCYP2A6
SCHEMBL27973487 0.78 CNR2 (0.36) MAOACYP3A4CYP1A2CYP2D6TSHR
SCHEMBL30140878 0.74 NOS3 (0.50) SCN4ALMNAMAOACYP3A4SCN1A
SCHEMBL2084135 0.74 NOS3 (0.50) SCN4ALMNAMAOACYP3A4SCN1A
SCHEMBL8404539 0.74 CYP2A6 (0.52) LMNAMAOACYP3A4CYP1A2TSHR
SCHEMBL23747533 0.74 NOS3 (0.50) SCN4ALMNAMAOACYP3A4SCN1A
SCHEMBL20482609 0.74 NOS3 (0.50) SCN4ALMNAMAOACYP3A4SCN1A
SCHEMBL6748371 0.73 LMNA (0.54) LMNACYP3A4TSHRSLC6A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219072-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 (CN) 2021-11-04 — — WO disclosed
Send feedback